Skip to main content
. Author manuscript; available in PMC: 2019 Jan 9.
Published in final edited form as: Biochemistry. 2017 Oct 31;57(1):117–135. doi: 10.1021/acs.biochem.7b00838

Table 2.

Apparent inactivation parameters for TβL, MetSox, and Glufos against E. coli, S. aureus, and human GS.

GS TβL MetSox Glufos
KI (μM) kinact (min−1) kinact/KI (min−1μM−1 ×103) KI (μM) kinact (min−1) kinact/KI (min−1μM−1 ×103) KI (μM) kinact (min−1) kinact/KI (min−1μM−1 ×103)
EC 1.7 ± 0.4a 0.3 ± 0.1 180 ± 70 3.9 ± 1.1 0.4 ± 0.1 100 ± 40 1.0 ± 0.2 0.7 ± 0.1 700 ± 200
SA 50 ± 10 0.4 ± 0.1 8 ± 3 13 ± 3 0.4 ± 0.1 28 ± 9 13 ± 3 0.4 ± 0.1 30 ± 10
H 130 ± 40 0.3 ± 0.1 2 ± 1 1000 ± 500 0.4 ± 0.2 0.4 ± 0.3 150 ± 60 0.9 ± 0.3 6 ± 3
a

All standard deviations were determined for three independent trials.